Tweet by Michael “Mike” Albert, MD on Twitter Posted byJoseph Thornton MDMay 21, 2022Posted inBlog Michael “Mike” Albert, MD @MichaelAlbertMD This is remarkable as tirzepatide (Mounjaro) produces ~40% more weight loss and ~40% greater reductions in A1c than Wegovy (semaglutide). 5/21/22, 9:45 AM Joseph Thornton Share this: Share on X (Opens in new window) X Share on Facebook (Opens in new window) Facebook Like Loading... Related Published by Joseph Thornton MD Teacher, Clinical Supervisor Clinical Associate Professor, Psychiatry University of Florida Affiliation is for identification only. All content and opinions are my own. View more posts
Gator Psychiatry 